# Marijuana and the Brain: Study Finds Memory and Decision-Making at Risk > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/heavy-cannabis-use-cognitive-impairments-memory-decision-risks/ > **Published:** 2026-04-01T09:23:03-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:33:01-04:00 > **Clinical Summary:** Explore heavy cannabis use cognitive impairments affecting memory and decision-making. Understand risks and clinical insights for patient counseling. --- ✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyResearchMental HealthTHCSafety Why This Matters This study provides clinicians with evidence of specific cognitive impairments associated with heavy [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), enabling more informed discussions with patients about concrete risks to memory and executive function. Understanding these neurobiological effects helps practitioners identify patients who may benefit from cessation counseling or cognitive monitoring, particularly those with occupational demands requiring intact decision-making. This research supports clinical risk-benefit conversations in jurisdictions where cannabis is legal or therapeutic, allowing evidence-based rather than assumption-based [patient counseling](https://cedclinic.com/stroke-risk-assessment-substance-use/). Clinical Summary This Spanish research study provides updated evidence on the neurocognitive consequences of heavy cannabis use, specifically documenting impairments in memory and decision-making processes. The findings suggest that chronic cannabis exposure produces measurable deficits in executive function and cognitive domains critical for daily functioning, adding to the growing body of literature on cannabis-related neurotoxicity with potential long-term clinical significance. For clinicians, these results support the importance of screening patients for baseline cognitive function before cannabis initiation and monitoring for decline in those using cannabis chronically, particularly heavy users who may be at greatest risk. The study underscores that cannabis is not cognitively neutral, especially in patterns of regular or dependent use, and should inform shared decision-making conversations with patients about risk versus benefit. Clinicians should counsel patients, particularly those in safety-sensitive occupations or with existing cognitive vulnerabilities, about potential memory and executive function impairment associated with heavy cannabis use. Dr. Caplan’s Take “The neuroimaging data we’re seeing on heavy cannabis use and prefrontal cortex function aligns with what I observe clinically in my long-term patients: impaired working memory and delayed decision-making that can persist even after cessation. This doesn’t mean occasional use carries the same risk profile, but it does mean we need to have honest conversations with patients about dose, frequency, and individual vulnerability factors before recommending cannabis therapeutically or assuming it’s benign.” Clinical Perspective While this study adds to growing evidence linking heavy cannabis use to [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/) in memory and decision-making domains, clinicians should recognize that most research to date has involved small samples, lacks rigorous long-term follow-up, and cannot fully disentangle cannabis effects from confounding factors such as concurrent substance use, mental health conditions, or socioeconomic stressors. The dose-response relationship remains poorly characterized, making it difficult to advise patients about safe consumption thresholds or to distinguish effects of heavy use from those of occasional or moderate use. Nevertheless, this finding reinforces the importance of screening patients—particularly adolescents and young adults whose brains remain developmentally vulnerable—for cannabis use patterns during routine clinical encounters, and of discussing potential cognitive risks as part of shared decision-making when patients are considering or already using cannabis therapeutically or recreationally. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Marijuana+and+the+brain%3A+Study+finds+memory+and+decision-making+at+risk+-+Radio+47+%40drcaplan&url=https%3A%2F%2Fwww.radio47.fm%2Fnews%2Fcannibis-25855%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.radio47.fm%2Fnews%2Fcannibis-25855%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Marijuana+and+the+brain%3A+Study+finds+memory+and+decision-making+at+risk+-+Radio+47+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.radio47.fm%2Fnews%2Fcannibis-25855%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Cannabis and the developing mind — regional and local doctors issue urgent warning to parents](https://cedclinic.com/cannabis-developing-mind-urgent-warning-parents/) - [Smoking weed and tobacco actually shrink your brain — here are the parts at risk](https://cedclinic.com/smoking-shrinks-key-brain-regions-cannabis-tobacco-effects/) - Cannabis and tobacco use linked to smaller brain volume – Medical Xpress 📰 Source: [https://www.radio47.fm/news/cannibis-25855/](https://www.radio47.fm/news/cannibis-25855/) Further Reading Cannabis Policy Wire[Policy Watch: 20 Regulatory Updates — March 20, 2026](https://cedclinic.com/drug-enforcement-controlled-substances-regulatory-policy-2026/) Research Digest[Research Digest: 5 Recent Studies – March 25, 2026](https://cedclinic.com/research-digest-recent-studies-march-2026/) Evidence Watch[Association of Cannabis Use Disorder Versus Other Substance Use Disorders With Psychiatric Conditions: A Propensity-Matched Retrospective Cohort Analysis.](https://cedclinic.com/cannabis-use-disorder-psychiatric-risk-profile/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [5 Long-Term Effects of Cannabis on Brain Activity and Cognitive Function – Liv Hospital](https://cedclinic.com/long-term-cannabis-effects-on-cognition/) Discover key long-term impacts of cannabis on brain activity and cognition, providing valuable insights for clinicians and patients. [Read More](https://cedclinic.com/long-term-cannabis-effects-on-cognition/) Long-term cannabis use may physically change structure of brain – The Times Explore research on how prolonged cannabis use can alter brain structure, emphasizing the importance of cognitive health monitoring. Learn More [LONG-TERM HEAVY CANNABIS USE LINKED TO THINNING IN FRONTAL BRAIN REGION](https://cedclinic.com/long-term-heavy-cannabis-use-linked-brain-changes/) Understand the association between heavy cannabis use and frontal brain region thinning, highlighting potential cognitive consequences. [Explore Study](https://cedclinic.com/long-term-heavy-cannabis-use-linked-brain-changes/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).